ASGE Masterclass: Barrett’s Esophagus, GERD and Esophageal Adenocarcinoma (On Demand) | February 2022-Quality is not just for Colonoscopy: Indicators in GERD and Barrett's Esophagus - It is time to incorporate these in to your practice

Quality is not just for Colonoscopy: Indicators in GERD and Barrett's Esophagus - It is time to incorporate these in to your practice

Back to course

Video Transcription

Video Summary

The video is a talk about quality indicators in Barrett's esophageal cancer. The speaker discusses the importance of measuring quality in endoscopy and the shift towards a value-based reimbursement system. They emphasize the need for physicians to track and report their performance in endoscopy and the potential linkage of reimbursement to quality measures. The speaker then focuses on quality indicators for Barrett's esophagus surveillance and endoscopic eradication therapy. They discuss the development of these indicators through a modified Delphi method and present several quality indicators for screening, diagnosis, and surveillance. The talk also covers the concept of neoplasia detection rate and its potential as a quality metric. The challenges of correlating volume and competency with outcomes in endoscopic eradication therapy are discussed. The speaker concludes by highlighting the need for continuous refinement and evaluation of quality indicators and addressing challenges in measuring, monitoring, reporting, and validating these metrics. The video does not provide any credits.

Keywords

quality indicators

Barrett's esophageal cancer

endoscopy

value-based reimbursement system

physician performance

Barrett's esophagus surveillance